{"count": 24, "results": [{"_id": "37108132", "pmid": 37108132, "pmcid": "PMC10138328", "title": "Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators", "journal": "Int J Mol Sci", "authors": ["Hambly R", "Kearney N", "Hughes R", "Fletcher JM", "Kirby B"], "date": "2023-04-09T00:00:00Z", "doi": "10.3390/ijms24086969", "meta_date_publication": "2023 Apr 9", "meta_volume": "24", "meta_issue": "8", "meta_pages": "", "score": 50293.957, "text_hl": "The mechanism of action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@HS@@@ is unknown. ", "citations": {"NLM": "Hambly R, Kearney N, Hughes R, Fletcher JM, Kirby B. Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators Int J Mol Sci. 2023 Apr 9;24(8):. PMID: 37108132", "BibTeX": "@article{37108132, title={Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators}, author={Hambly R and Kearney N and Hughes R and Fletcher JM and Kirby B}, journal={Int J Mol Sci}, volume={24}, number={8}}"}}, {"_id": "30893570", "pmid": 30893570, "title": "Metformin use in hidradenitis suppurativa.", "journal": "J Dermatolog Treat", "authors": ["Jennings L", "Hambly R", "Hughes R", "Moriarty B", "Kirby B"], "date": "2020-05-01T00:00:00Z", "doi": "10.1080/09546634.2019.1592100", "meta_date_publication": "2020 May", "meta_volume": "31", "meta_issue": "3", "meta_pages": "261-263", "score": 50288.8, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use in @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@hidradenitis suppurativa@@@.", "citations": {"NLM": "Jennings L, Hambly R, Hughes R, Moriarty B, Kirby B. Metformin use in hidradenitis suppurativa. J Dermatolog Treat. 2020 May;31(3):261-263. PMID: 30893570", "BibTeX": "@article{30893570, title={Metformin use in hidradenitis suppurativa.}, author={Jennings L and Hambly R and Hughes R and Moriarty B and Kirby B}, journal={J Dermatolog Treat}, volume={31}, number={3}, pages={261-263}}"}}, {"_id": "37325287", "pmid": 37325287, "title": "Metformin in Hidradenitis Suppurativa: Is It Worth Pursuing Further?", "journal": "Skin Appendage Disord", "authors": ["Tsentemeidou A", "Vakirlis E", "Papadimitriou I", "Ioannides D", "Sotiriou E"], "date": "2023-06-01T00:00:00Z", "doi": "10.1159/000529359", "meta_date_publication": "2023 Jun", "meta_volume": "9", "meta_issue": "3", "meta_pages": "187-190", "score": 50285.8, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@Hidradenitis Suppurativa@@@: Is It Worth Pursuing Further?", "citations": {"NLM": "Tsentemeidou A, Vakirlis E, Papadimitriou I, Ioannides D, Sotiriou E. Metformin in Hidradenitis Suppurativa: Is It Worth Pursuing Further? Skin Appendage Disord. 2023 Jun;9(3):187-190. PMID: 37325287", "BibTeX": "@article{37325287, title={Metformin in Hidradenitis Suppurativa: Is It Worth Pursuing Further?}, author={Tsentemeidou A and Vakirlis E and Papadimitriou I and Ioannides D and Sotiriou E}, journal={Skin Appendage Disord}, volume={9}, number={3}, pages={187-190}}"}}, {"_id": "37972134", "pmid": 37972134, "title": "The antidiabetic medicine metformin has beneficial effects in hidradenitis suppurativa.", "journal": "Br J Dermatol", "date": "2023-11-16T00:00:00Z", "doi": "10.1093/bjd/ljad417", "meta_date_publication": "2023 Nov 16", "meta_volume": "189", "meta_issue": "6", "meta_pages": "e111", "score": 50279.926, "text_hl": "The antidiabetic medicine @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has beneficial effects in @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@hidradenitis suppurativa@@@.", "citations": {"NLM": "The antidiabetic medicine metformin has beneficial effects in hidradenitis suppurativa. Br J Dermatol. 2023 Nov 16;189(6):e111. PMID: 37972134", "BibTeX": "@article{37972134, title={The antidiabetic medicine metformin has beneficial effects in hidradenitis suppurativa.}, journal={Br J Dermatol}, volume={189}, number={6}, pages={e111}}"}}, {"_id": "39746651", "pmid": 39746651, "title": "RF - Metformin as part of the therapeutic armamentarium of hidradenitis suppurativa.", "journal": "Actas Dermosifiliogr", "authors": ["Salvador JC", "Martínez Fernández A", "Chiloeches Fernández C"], "date": "2024-12-31T00:00:00Z", "doi": "10.1016/j.ad.2024.04.031", "meta_date_publication": "2024 Dec 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50279.7, "text_hl": "RF - @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as part of the therapeutic armamentarium of @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@hidradenitis suppurativa@@@.", "citations": {"NLM": "Salvador JC, Martínez Fernández A, Chiloeches Fernández C. RF - Metformin as part of the therapeutic armamentarium of hidradenitis suppurativa. Actas Dermosifiliogr. 2024 Dec 31;():. PMID: 39746651", "BibTeX": "@article{39746651, title={RF - Metformin as part of the therapeutic armamentarium of hidradenitis suppurativa.}, author={Salvador JC and Martínez Fernández A and Chiloeches Fernández C}, journal={Actas Dermosifiliogr}}"}}, {"_id": "33346525", "pmid": 33346525, "title": "Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.", "journal": "J Drugs Dermatol", "authors": ["Moussa C", "Wadowski L", "Price H", "Mirea L", "O'Haver J"], "date": "2020-12-01T00:00:00Z", "doi": "10.36849/JDD.2020.5447", "meta_date_publication": "2020 Dec 1", "meta_volume": "19", "meta_issue": "12", "meta_pages": "1231-1234", "score": 50277.184, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as Adjunctive Therapy for Pediatric @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@Hidradenitis Suppurativa@@@.", "citations": {"NLM": "Moussa C, Wadowski L, Price H, Mirea L, O'Haver J. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa. J Drugs Dermatol. 2020 Dec 1;19(12):1231-1234. PMID: 33346525", "BibTeX": "@article{33346525, title={Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.}, author={Moussa C and Wadowski L and Price H and Mirea L and O'Haver J}, journal={J Drugs Dermatol}, volume={19}, number={12}, pages={1231-1234}}"}}, {"_id": "38078688", "pmid": 38078688, "pmcid": "PMC10726377", "title": "Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea", "journal": "Acta Derm Venereol", "authors": ["Cho M", "Woo YR", "Cho SH", "Lee JD", "Kim HS"], "date": "2023-12-11T00:00:00Z", "doi": "10.2340/actadv.v103.18392", "meta_date_publication": "2023 Dec 11", "meta_volume": "103", "meta_issue": "", "meta_pages": "adv18392", "score": 50270.684, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: A Potential Treatment for @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@Acne@@@, @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@Hidradenitis Suppurativa@@@ and @DISEASE_Rosacea @DISEASE_MESH:D012393 @@@Rosacea@@@", "citations": {"NLM": "Cho M, Woo YR, Cho SH, Lee JD, Kim HS. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea Acta Derm Venereol. 2023 Dec 11;103():adv18392. PMID: 38078688", "BibTeX": "@article{38078688, title={Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea}, author={Cho M and Woo YR and Cho SH and Lee JD and Kim HS}, journal={Acta Derm Venereol}, volume={103}, pages={adv18392}}"}}, {"_id": "37648653", "pmid": 37648653, "title": "Metformin has anti-inflammatory effects and induces immunometabolic reprogramming in hidradenitis suppurativa via multiple mechanisms.", "journal": "Br J Dermatol", "authors": ["Petrasca A", "Hambly R", "Kearney N", "Smith CM", "Pender EK", "Mac Mahon J", "O'Rourke AM", "Ismaiel M", "Boland PA", "Almeida JP", "Kennedy C", "Zaborowski A", "Murphy S", "Winter D", "Kirby B", "Fletcher JM"], "date": "2023-08-30T00:00:00Z", "doi": "10.1093/bjd/ljad305", "meta_date_publication": "2023 Aug 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50270.367, "text_hl": "While @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is not licenced for use in @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@HS@@@, @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@HS@@@ patients taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ show improved clinical symptoms. ", "citations": {"NLM": "Petrasca A, Hambly R, Kearney N, Smith CM, Pender EK, Mac Mahon J, O'Rourke AM, Ismaiel M, Boland PA, Almeida JP, Kennedy C, Zaborowski A, Murphy S, Winter D, Kirby B, Fletcher JM. Metformin has anti-inflammatory effects and induces immunometabolic reprogramming in hidradenitis suppurativa via multiple mechanisms. Br J Dermatol. 2023 Aug 30;():. PMID: 37648653", "BibTeX": "@article{37648653, title={Metformin has anti-inflammatory effects and induces immunometabolic reprogramming in hidradenitis suppurativa via multiple mechanisms.}, author={Petrasca A and Hambly R and Kearney N and Smith CM and Pender EK and Mac Mahon J and O'Rourke AM and Ismaiel M and Boland PA and Almeida JP and Kennedy C and Zaborowski A and Murphy S and Winter D and Kirby B and Fletcher JM}, journal={Br J Dermatol}}"}}, {"_id": "37026880", "pmid": 37026880, "title": "Update on Hormonal Therapy in Hidradenitis Suppurativa.", "journal": "J Drugs Dermatol", "authors": ["Karagaiah P", "Daveluy S", "Ortega-Loayza A", "Gulliver W", "Szepietowski J", "Grabbe S", "Goldust M"], "date": "2023-04-01T00:00:00Z", "doi": "10.36849/JDD.6235", "meta_date_publication": "2023 Apr 1", "meta_volume": "22", "meta_issue": "4", "meta_pages": "369-374", "score": 50268.22, "text_hl": "In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@HS@@@, including @CHEMICAL_Finasteride @CHEMICAL_MESH:D018120 @@@finasteride@@@, @CHEMICAL_Cyproterone_Acetate @CHEMICAL_MESH:D017373 @@@cyproterone acetate@@@, @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@, oral contraceptive pills, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Karagaiah P, Daveluy S, Ortega-Loayza A, Gulliver W, Szepietowski J, Grabbe S, Goldust M. Update on Hormonal Therapy in Hidradenitis Suppurativa. J Drugs Dermatol. 2023 Apr 1;22(4):369-374. PMID: 37026880", "BibTeX": "@article{37026880, title={Update on Hormonal Therapy in Hidradenitis Suppurativa.}, author={Karagaiah P and Daveluy S and Ortega-Loayza A and Gulliver W and Szepietowski J and Grabbe S and Goldust M}, journal={J Drugs Dermatol}, volume={22}, number={4}, pages={369-374}}"}}, {"_id": "32845585", "pmid": 32845585, "title": "Oral Metformin for Treating Dermatological Diseases: A Systematic Review.", "journal": "J Drugs Dermatol", "authors": ["Sung CT", "Chao T", "Lee A", "Foulad DP", "Choi F", "Juhasz M", "Dobry A", "Mesinkovska NA"], "date": "2020-08-01T00:00:00Z", "doi": "10.36849/JDD.2020.4874", "meta_date_publication": "2020 Aug 1", "meta_volume": "19", "meta_issue": "8", "meta_pages": "713-720", "score": 50265.043, "text_hl": "...Introduction:@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is an antihyperglycemic medication most commonly used to treat @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type II Diabetes Mellitus@@@ with promising off-label application for the treatment of @<m>DISEASE_Hidradenitis_Suppurativa</m> @DISEASE_MESH:D017497 @@@hidradenitis suppurativa@@@, @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@psoriasis@@@, @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@, @DISEASE_Acanthosis_Nigricans @DISEASE_MESH:D000052 @@@acanthosis nigricans@@@, and @DISEASE_Hirsutism @DISEASE_MESH:D006628 @@@hirsutism@@@. ", "citations": {"NLM": "Sung CT, Chao T, Lee A, Foulad DP, Choi F, Juhasz M, Dobry A, Mesinkovska NA. Oral Metformin for Treating Dermatological Diseases: A Systematic Review. J Drugs Dermatol. 2020 Aug 1;19(8):713-720. PMID: 32845585", "BibTeX": "@article{32845585, title={Oral Metformin for Treating Dermatological Diseases: A Systematic Review.}, author={Sung CT and Chao T and Lee A and Foulad DP and Choi F and Juhasz M and Dobry A and Mesinkovska NA}, journal={J Drugs Dermatol}, volume={19}, number={8}, pages={713-720}}"}}]}